Hiroshima City Asa Citizens Hospital
In research, Hiroshima City Asa Citizens Hospital stands highest in Medicine (#6,409 of 10,443 worldwide) and Health Sciences (#8,193 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Pulmonary and Respiratory Medicine and Surgery — Pulmonary and Respiratory Medicine is 9.4× its share of world research.
- World rank, 2022–2025
- #17,105 of 28,054 · #30,994 all time
- Rank in Japan
- #460 of 1,070
- Research works
- 1k ▲ 47% vs 2013–17
- Citations
- 7.3k 7.0 per fractional work
- Top-10% rate
- 6.7% record average 16.5%
- Open access
- 54% world 28%
What is Hiroshima City Asa Citizens Hospital known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #6,409 of 10,443 | 6.2% | 218 | #10596 | |
| Health SciencesDomain | #8,193 of 11,982 | 6.4% | 223 | #13599 |
Each strip is that field’s whole ranked pool, with the notch where Hiroshima City Asa Citizens Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Hiroshima City Asa Citizens Hospital specialise in?
Where its research is concentrated relative to its size: Pulmonary and Respiratory Medicine takes 9.4× the share of its output that it takes of world research.
- Pulmonary and Respiratory MedicineSubfield · 36.7 works9.4×
- SurgerySubfield · 42.5 works7.1×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.5×. Every wedge is a field page.
- Medicine 4.5×
- Immunology and Microbiology 1.9×
- Neuroscience 1.5×
- Dentistry 1.0×
- Biochemistry, Genetics and Molecular Biology 0.9×
- Veterinary 0.8×
- Pharmacology, Toxicology and Pharmaceutics 0.8×
- Nursing 0.6×
- Health Professions 0.4×
- Psychology 0.2×
- Environmental Science 0.1×
- Physics and Astronomy 0.1×
- Engineering 0.1×
- Agricultural and Biological Sciences 0.0×
- Chemistry 0.0×
- Computer Science 0.0×
- Materials Science 0.0×
- Mathematics 0.0×
- Arts and Humanities 0.0×
- Decision Sciences 0.0×
- Economics, Econometrics and Finance 0.0×
- Earth and Planetary Sciences 0.0×
- Business, Management and Accounting 0.0×
- Social Sciences 0.0×
Who are the top researchers at Hiroshima City Asa Citizens Hospital?
Ranked on the composite score, Kazuhiro Okada, Akira Fukumoto and Yasuhiro Choda lead among researchers whose main affiliation is Hiroshima City Asa Citizens Hospital.
- 1 Kazuhiro Okada Japan · #172,887 worldwide 157 citations · 22 works
- 2 Akira Fukumoto Japan · #252,039 worldwide 56 citations · 38 works
- 3 Yasuhiro Choda Japan · #262,711 worldwide 95 citations · 29 works
- 4 Michiaki Nagai Japan · #330,998 worldwide 102 citations · 28 works
- 5 Shota Sasaki Japan · #411,098 worldwide 111 citations · 43 works
- 6 Hiroyoshi Matsukawa Japan · #574,547 worldwide 32 citations · 26 works
- 7 Mayumi Kaneko Japan · #632,532 worldwide 33 citations · 30 works
- 8 Hidenori Mukaida Japan · #715,992 worldwide 20 citations · 22 works
- 9 Masao Harano Japan · #746,098 worldwide 17 citations · 19 works
- 10 Yu Sato Japan · #836,461 worldwide 6 citations · 18 works
Which keywords describe research at Hiroshima City Asa Citizens Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Chemotherapy, Diagnosis, Surgical Management, Prognostic Factors, Immunotherapy, Treatment and Neoadjuvant Therapy.
- Lymph Node Dissection
- Autoimmune
- Echocardiography
- Esophageal Carcinoma
- Gastric Cancer
- Targeted Therapy
- Chemoradiation
- Heart Failure
- Preoperative Chemoradiotherapy
- Complications
- Adjuvant Therapy
- Autoantibodies
- Survival Analysis
- Risk Factors
- Surgery
- Clinical Practice Guidelines
- Prognostic Factors
- Surgical Management
- Treatment
- Chemotherapy
- Epidemiology
- Diagnosis
- Inflammation
- Immunotherapy
- Neoadjuvant Therapy
- Management
- Endoscopic Resection
- Genetic Mutations
- Meta-Analysis
- Radiotherapy
- Tumor Microenvironment
- Molecular Characterization
- Clinical Trials
- Guidelines
- Classification
- Thrombosis
- Barrett's Esophagus
- Endovascular Treatment
- Imatinib Mesylate
- Neoadjuvant Chemotherapy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology31▲ 3.1×78 topics
- Chemotherapy20▲ 11×22 topics
- Diagnosis17▲ 7.3×30 topics
- Treatment15▲ 4.8×31 topics
- Inflammation13▲ 2.5×43 topics
- Surgical Management13▲ 12×18 topics
- Immunotherapy12▲ 6.9×18 topics
- Prognostic Factors12▲ 11×13 topics
- Neoadjuvant Therapy11▲ 19×5 topics
- Clinical Practice Guidelines11▲ 8.0×14 topics
- Management11▲ 5.5×24 topics
- Surgery10▲ 12×8 topics
- Endoscopic Resection10▲ 40×2 topics
- Risk Factors9▲ 3.2×21 topics
- Genetic Mutations9▲ 8.1×15 topics
- Survival Analysis8▲ 12×6 topics
- Meta-Analysis8▲ 5.4×7 topics
- Autoantibodies8▲ 13×8 topics
- Radiotherapy8▲ 7.7×11 topics
- Adjuvant Therapy7▲ 22×2 topics
- Tumor Microenvironment7▲ 6.4×7 topics
- Complications7▲ 5.4×12 topics
- Molecular Characterization7▲ 15×5 topics
- Preoperative Chemoradiotherapy7▲ 34×2 topics
- Clinical Trials7▲ 3.9×9 topics
- Heart Failure7▲ 6.0×12 topics
- Guidelines6▲ 5.2×12 topics
- Chemoradiation6▲ 36×2 topics
- Classification6▲ 5.0×4 topics
- Targeted Therapy6▲ 10×4 topics
- Thrombosis6▲ 8.0×7 topics
- Gastric Cancer6▲ 20×3 topics
- Barrett's Esophagus6▲ 54×1 topic
- Esophageal Carcinoma6▲ 54×1 topic
- Endovascular Treatment5▲ 36×2 topics
- Echocardiography5▲ 7.4×8 topics
- Imatinib Mesylate5▲ 39×2 topics
- Autoimmune5▲ 39×2 topics
- Neoadjuvant Chemotherapy5▲ 23×2 topics
- Lymph Node Dissection4▲ 30×1 topic
Which research topics does Hiroshima City Asa Citizens Hospital publish most on?
By volume in 2022–2025: Esophageal Cancer Research and Treatment, Gastric Cancer Management and Outcomes, Esophageal and GI Pathology and Intracranial Aneurysms: Treatment and Complications.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Esophageal Cancer Research and Treatment Surgery 6 works
- 2 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 4 works
- 3 Esophageal and GI Pathology Surgery 4 works
- 4 Intracranial Aneurysms: Treatment and Complications Neurology 4 works
- 5 Urticaria and Related Conditions Rheumatology 3 works
- 6 Lung Cancer Research Studies Oncology 3 works
- 7 Pancreatic and Hepatic Oncology Research Oncology 3 works
- 8 Gastrointestinal Tumor Research and Treatment Gastroenterology 3 works
- 9 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 3 works
- 10 Coagulation, Bradykinin, Polyphosphates, and Angioedema Genetics 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Hiroshima City Asa Citizens Hospital's research output changed?
Output in 2018–2022 was 47% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Hiroshima
- Hiroshima University
- Hiroshima University Hospital
- Hiroshima City University
- Hiroshima Institute of Technology
- Prefectural University of Hiroshima
- Hiroshima University of Economics
- Hiroshima Prefectural Hospital
- Mazda Motor Corporation (Japan)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.